Doctor profile · Federal record
Dr. Harvind Chahal, MD
Dermatology Physician (CMS: Dermatology) · Oakland, CA
- NPI 1508392168
- Accepts Medicare
- 9 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
3100 Telegraph Ave
Oakland, CA 946093239
(510) 204-8168
fax (510) 903-9037 - Additional location
-
12 Camino Encinas
Orinda, CA 945633304
(925) 776-7725
fax (510) 506-7721 - Mailing address
-
325 Distel Cir Ste 380
Los Altos, CA 940221408
Credentials & registration
- NPI registered
- May 2017 — 9 yrs on file
- Profile last updated
- April 16, 2024
- Year of graduation
- 2017 — 9 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- California #A159061
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1508392168. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,202
Distinct HCPCS
10
Medicare allowed
$144,397
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
96910 |
Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 325 | 26 | $118 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 248 | 194 | $151 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 164 | 29 | $9 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 125 | 111 | $107 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 99 | 87 | $214 | |
17110 |
Destruction of skin growth, 1-14 growths | 52 | 48 | $146 | |
11102 |
Biopsy of related skin growth, first growth | 49 | 47 | $127 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 49 | 49 | $194 | |
17000 |
Destruction of precancer skin growth, 1 growth | 48 | 43 | $76 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 43 | 43 | $132 |
In context: peer comparison
Among 6 peers in this city , average services per provider: 163. This provider delivers 7.4× the peer median.Open Payments
Industry payments received
All-time total
$891
Transactions
17
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 4 | $313.17 | |
| GENZYME CORPORATION | 2 | $155.13 | |
| Janssen Biotech, Inc. | 3 | $153.69 | |
| Incyte Corporation | 1 | $111.34 | |
| PFIZER INC. | 2 | $39.65 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $37.64 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $28.67 | |
| Novartis Pharmaceuticals Corporation | 1 | $27.77 | |
| Dermavant Sciences, Inc. | 1 | $23.89 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,391
Patients
775
Total drug cost
$222,472
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 312 | 178 | $5,101 |
| Clobetasol Propionate | Generic | 280 | 147 | $23,385 |
| Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) | Brand | 153 | 97 | $6,932 |
| Hydrocortisone | Generic | 139 | 81 | $768 |
| Ketoconazole | Generic | 122 | 70 | $2,817 |
| Tacrolimus | Generic | 82 | 46 | $13,819 |
| Metronidazole | Generic | 50 | 27 | $3,165 |
| Fluocinonide | Generic | 45 | 24 | $2,741 |
| Dupixent Pen (Dupilumab) | Brand | 42 | 0 | $157,861 |
| Doxycycline Hyclate | Generic | 34 | 23 | $3,359 |
Frequently asked questions
What is Dr. Harvind Chahal's medical specialty?
Dr. Harvind Chahal practices Dermatology Physician in Oakland, CA.
Where does Dr. Harvind Chahal practice?
Dr. Harvind Chahal practices at 3100 Telegraph Ave, Oakland, CA 946093239. Office phone: 5102048168.
What is Dr. Harvind Chahal's NPI?
Dr. Harvind Chahal's National Provider Identifier (NPI) is 1508392168, issued by NPPES.
Does Dr. Harvind Chahal accept Medicare assignment?
Yes. Dr. Harvind Chahal accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Harvind Chahal commonly perform?
Top Medicare-reported procedures in 2023: Therapy procedure using ultraviolet radiation with tar or petroleum jelly application (HCPCS 96910); Established patient office or other outpatient visit (HCPCS 99214); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003). Source: CMS Medicare Physician & Other Practitioners file.